secwatch.observer — SEC 8-K summary
======================================

Issuer:     GENELUX Corp (GNLX)
CIK:        0001231457
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001641172-25-000642
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genelux prices $10.5M underwritten offering of 3M shares at $3.50/share
-----------------------------------------------------------------------

- Gross proceeds of $10.5M from 3,000,000 shares at $3.50 per share; closing expected March 26, 2025.
- Underwriter receives warrant to purchase 120,000 shares at $4.20 per share, exercisable after 180 days.
- Proceeds for working capital and continued clinical development of Olvi-Vec.
- Titan Partners Group acting as sole bookrunner; offering under effective shelf registration S-3.
- Shares sold in registered direct offering; underwriting discounts and expenses not yet disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/0001641172-25-000642-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1231457/000164117225000642/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000642

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer